This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Inverness Medical Innovations Q1 2010 Earnings Call Transcript

Inverness Medical Innovations (IMA)

Q1 2010 Earnings Call

April 28, 2010 10:00 am ET

Executives

Doug Guarino - Director of Corporate Communications & Corporate Relations

David Teitel - Chief Financial Officer, Principal Accounting Officer, Vice President and Treasurer

Ron Zwanziger - Chairman of the Board, Chief Executive Officer and President

Analysts

Bruce Cranna - Jefferies & Company, Inc.

Ashim Anand - Natixis Bleichroeder Inc.

Erik Schneider - UBS Investment Bank

Bill Bonello - RBC Capital Markets Corporation

Jonathan Groberg - Macquarie Research

Jeff Ares

Gregory Simpson - Stifel, Nicolaus & Co., Inc.

Mark Afrasiabi - PIMCO

John Putnam - Capstone Investments

Zarak Khurshid - Caris & Company

Constantine Davides - JMP Securities LLC

Daniel Owczarski - Avondale Partners LLC

Presentation

Operator

Good morning, and welcome to the First Quarter Earnings Conference Call. My name is Suzette, and I will be facilitating the audio portion of today's interactive broadcast. [Operator Instructions] At this time, I would like to turn the event over to Doug Guarino, Director of Corporate Relations. Sir, you may begin your conference.

Doug Guarino

Well, thank you, Suzette, and good morning, and welcome to the Inverness Medical Innovations Conference Call to discuss our results for the quarter and year ended March 31, 2010. We are joined today by Ron Zwanziger, Chairman and CEO; and Dave Teitel, our CFO.

Before we get to that discussion though, I would first like to draw your attention to the fact that certain matters discussed in this conference call will constitute forward-looking statements within the meaning of U.S. securities laws. These statements reflect our current views with respect to future events of financial performance and are based on management’s current assumptions and information currently available.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs